Efficacy (27%) Indications The approved indications for all 7 GLP-1RAs in China are for glycemic control in adult patients with T2DM
Questions Women Are Asking Multiple studies, like one for the American Diabetes Association in 2013, suggest that time spent with fasting blood glucose above 100 mg/dL is associated with increased risk of cardiovascular disease and mortality
H., Ergenc, M
Theyre not the same as a free PAP, but they do represent a more manageable cost floor than paying $700+ out of pocket through a retail pharmacy. Trump Administration Pricing Agreements In November 2025, President Trump finalized pricing agreements with Eli Lilly and Novo Nordisk that starting in mid-2026 will allow Medicare to cover GLP-1s for obesity for the first time, with a $50/month patient copay
While GLP-1 receptor agonists (such as semaglutide and liraglutide) have demonstrated significant benefits in diabetes management, weight reduction, and cardiovascular outcomes in clinical trials, enhancing physiological GLP-1 through dietary and lifestyle modifications represents a foundational approach
All treatment is guided by lab results and physician evaluation